Opinion
2023-1395 2023-1396
07-09-2024
REGENERON PHARMACEUTICALS, INC., Appellant v. MYLAN PHARMACEUTICALS INC., CELLTRION, INC., APOTEX INC., Appellees
This order is nonprecedential.
Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2021-00880, IPR2021-00881, IPR2022-00257, IPR2022-00258, IPR2022-00298, IPR2022-00301.
ORDER
The parties, having so agreed, IT IS ORDERED THAT:
The above-captioned appeals are dismissed under Fed. R. App. P. 42(b) with each side to bear their own costs.